Therapeutic Prospects for the Prevention of Neurodegeneration in Huntington's Disease and the Polyglutamine Repeat Disorders

Publisher： Bentham Science Publishers

E-ISSN： 1875-5607|7|1|99-106

ISSN： 1389-5575

Source： Mini Reviews in Medicinal Chemistry, Vol.7, Iss.1, 2007-01, pp. : 99-106

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Targeting aggregation in the development of therapeutics for the treatment of Huntington’s disease and other polyglutamine repeat diseases

By Steffan Joan S   Thompson Leslie Michels  

Expert Opinion on Therapeutic Targets, Vol. 7, Iss. 2, 2003-04 ,pp. : 201-213

Informa Healthcare

Access to resources Recommend Favorite

Therapeutic strategies in Huntington’s disease

By Alberch Jordi   Canals Josep M   Pérez-Navarro Esther  

Expert Opinion on Therapeutic Patents, Vol. 13, Iss. 4, 2003-04 ,pp. : 449-465

Informa Healthcare

Access to resources Recommend Favorite

Phosphodiesterases as Therapeutic Targets for Huntington’s Disease

By  

Current Pharmaceutical Design, Vol. 21, Iss. 3, 2015-01 ,pp. : 365-377

Bentham Science Publishers

Access to resources Recommend Favorite

The Role of Iron in Neurodegeneration: Prospects for Pharmacotherapy of Parkinson's Disease

By Jellinger K.A.  

Drugs & Aging, Vol. 14, Iss. 2, 1999-02 ,pp. : 115-140

Adis International

Access to resources Recommend Favorite

Novel therapeutic targets for Huntington’s disease

By Hannan Anthony J  

Expert Opinion on Therapeutic Targets, Vol. 9, Iss. 4, 2005-08 ,pp. : 639-650

Informa Healthcare

Access to resources Recommend Favorite